StockData
Genmab A/S logo

Genmab A/S

GMABNasdaqPharmaceutical PreparationsAlso trades as GNMSF
Financials through fiscal 2025, year ended Dec 31, 2025Score 0/30
$51.35+0.38 (+0.75%)

Close on Nov 19, 2026

Genmab A/S Term Loan A Credit Facility (Amortizing) by Quarter

Term Loan A Credit Facility (Amortizing) ($M)

Genmab A/S Term Loan A Credit Facility (Amortizing): $926M in Q3 2026.

Latest, Q3 2026
926
Period ended Sep 30, 2026
Change on a year earlier
–
History
4 quarters
Since Q4 2025
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“|| Ending Balance as of 9/30/2026 | $ | 926 | $ | 1,674 | $ | 1,439 | $ | 953 | $ | 4,992”

Source: Genmab Form 6-K — Q3 2026 Interim Report (Nine Months Ended Sep 30, 2026) ↗

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Genmab A/S Term Loan A Credit Facility (Amortizing) ($M), quarterly Q4 2025–Q3 2026 [Data set]. Compiled from Genmab A/S SEC filings and investor materials. https://stockdatahq.com/stocks/gmab/kpis/debt-term-a

See every metric in the Genmab A/S KPI table. Data updated Nov 11, 2026.

See a number that looks wrong?